Quest Diagnostics (NYSE:DGX) Given New $166.00 Price Target at UBS Group
Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by investment analysts at UBS Group from $165.00 ...
Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base
Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, and offers 2.0% dividend yield.
Zacks.com on MSN2d
DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up
Quest Diagnostics Incorporated’s DGX third-quarter 2024 adjusted earnings per share (EPS) of $2.30 beat the Zacks Consensus ...
Zacks.com on MSN1d
DGX or PNTG: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Quest Diagnostics (DGX) or The Pennant Group, Inc. (PNTG). But which of these two ...
Quest Diagnostics awarded several contracts by CDC
Quest Diagnostics (DGX) announced that it has been awarded several contracts by the U.S. Centers for Disease Control and Prevention, or CDC, to ...
Quest Diagnostics (DGX) Receives a Hold from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Hold rating on Quest Diagnostics (DGX – Research ...
Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS. Read why I ...
news.stocktradersdaily6d
When (DGX) Moves Investors should Listen
Check the time stamp on this data. Updated AI-Generated Signals for Quest Diagnostics Incorporated (DGX) available here: DGX.